EGFR and breast cancer: The epidermal growth factor receptor (EGFR) ligand amphiregulin (AREG) is shown to be required for YAP-induced proliferation in breast cancer cells [143], thus suggesting that EGFR signaling is an important YAP effector, regulating both physiological and malignant cell proliferation.